Pharmafile Logo

Onyx Health Wins New MedTech Client

Onyx Health have recently bagged a new business win with Cambridge based MedTech company Medovate to launch their pioneering medical device SAFIRA in the United States

Newcastle based healthcare marketing communication specialists Onyx Health have secured new business with Cambridge MedTech company Medovate to launch their pioneering medical device SAFIRA (SAFer Injection for Regional Anaesthesia) in the United States.

The SAFIRA device offers a safer solution for regional anaesthesia procedures by limiting the injection pressure threshold.

This helps to reduce the risk of nerve damage during procedures, as well as saving time and cutting costs by making the normally two-person procedure of administering regional anaesthesia into a one-person procedure.

Medovates’ stateside launch of SAFIRA is all set for later in the year to take advantage of the rapidly growing international healthcare market. Onyx Health will be providing a full range of communication, digital and marketing support prior to the launch.

Commenting on working with Medovate, Associate Director, Trevor Pill said

“At Onyx Health we’re specialists in medical technology and are delighted to be working with Medovate. Innovation is one of the key drivers behind the growth of the MedTech sector in the UK and SAFIRA is very much at its cutting edge.

This product will benefit patients and clinicians alike saving time, cutting costs and delivering better patient outcomes.”

Chris Rogers, Sales and Marketing Director at Medovate added “Onyx Health’s knowledge and expertise in the healthcare sector will be instrumental is facilitating the launch of our SAFIRA device in the United States.

We’ve got ambitious plans to access global healthcare markets with this device, Onyx’s track record of helping their clients go global will be crucial to turning this into a reality.”

This content was provided by Onyx Health

Company Details

 Latest Content from  Onyx Health 

Onyx Health receive national recognition as a “one to watch” business in Newcastle

Specialist marketing communications agency Onyx Health have been nationally recognised by The Sunday Times as one of six “one to watch” businesses based in Newcastle.

Blueberry Therapeutics receives clearance from the FDA to proceed with the clinical investigation of BB2603

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603

Top five digital design tips for healthcare companies

Getting the right digital design is essential for healthcare and pharma companies, here are the five things I think all businesses should consider

Onyx Health Launch ‘Game-changing’ New Digital Offer

Onyx Health have recently launched a new digital offering to bridge the digital skills gap in the pharma and healthcare sectors